Inhibitors of Caspases

Details for Australian Patent Application No. 2003255217 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Forster, Cornelia J.; Shi, Zhan; Grillot, Anne-Laure; Davies, Robert J.; Janetka, James W.; Wilson, Keith P.; Murcko, Mark A.; Mullican, Michael D.; Lauffer, David J.; Charifson, Paul S.; Bemis, Guy W.; Wannamaker, Marion W.

Agent Cullen & Co

Pub. Number AU-A-2003255217

Parent 30986

Filing date 22 October 2003

Wipo publication date 13 November 2003

International Classifications

C07K 005/023 Peptides having up to four amino acids in a fully defined sequence

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61K 038/03 Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

A61K 031/47 - Quinolines

A61K 038/04 Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

Event Publications

6 November 2003 Complete Application Filed

13 November 2003 Application Open to Public Inspection

  Published as AU-A-2003255217

22 February 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255218-Manufacturing method of structural body and structural body

2003255216-Nickel-base superalloy